Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Chem ; 157: 791-804, 2018 Sep 05.
Article in English | MEDLINE | ID: mdl-30144697

ABSTRACT

A short and efficient route to 4-(4-hydroxyphenyl)cycloheptanemethanol was developed, which resulted in the preparation of a mixture of 4 stereoisomers. The stereoisomers were separated by preparative HPLC, and two of the stereoisomers identified by X-ray crystallography. The stereoisomers, as well as a small family of 4-cycloheptylphenol derivatives, were evaluated as estrogen receptor-beta agonists. The lead compound, 4-(4-hydroxyphenyl)cycloheptanemethanol was selective for activating ER relative to seven other nuclear hormone receptors, with 300-fold selectivity for the ß over α isoform and with EC50 of 30-50 nM in cell-based and direct binding assays.


Subject(s)
Antineoplastic Agents/pharmacology , Cycloheptanes/pharmacology , Estrogen Receptor beta/agonists , Estrogens/pharmacology , Methanol/pharmacokinetics , Phenols/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Crystallography, X-Ray , Cycloheptanes/chemical synthesis , Cycloheptanes/chemistry , Cycloheptanes/pharmacokinetics , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Estrogens/chemical synthesis , Estrogens/chemistry , Humans , MCF-7 Cells , Methanol/chemical synthesis , Methanol/chemistry , Models, Molecular , Molecular Structure , Phenols/chemical synthesis , Phenols/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...